Caring for wounds is both art and science. You provide the dedication and skill to your patients – 3M provides unparalleled solutions developed by empathetic experts who apply science to your healthcare challenges. But in this time of the COVID-19 pandemic, healthcare treatments may have been delayed, resulting in the loss of precious healing time. 3M products can help promote wound healing and bring the focus back to wound healing with wound management tools such as negative pressure wound therapy and advanced wound care options that may help reduce the risk of infections, reduce the risk of complications and get patients back to their lives.
Now more than ever, patients need reassurance that they don’t have to manage their wounds alone while recovering and healing.
Clinicians also need a trusted partner that goes beyond selling products to providing trusted solutions and best-in-class service.
3M gives you the protocols, proven portfolios and expert support that enable you to focus on delivering clinical and economic outcomes.
When you’re there for your patients, 3M is here for you, helping to bring certainty in uncertain times.
Let us contact you for more support.
COVID-19 has dramatically changed the healthcare landscape for you and your wound care patients. Now, as your patients seek advanced modalities to help them get back to their lives, 3M is here to help.
As the leader in Negative Pressure Wound Therapy (NPWT), 3M delivers innovative wound care technologies and evidence-based outcomes to suit you and your patient’s needs.
You'll need powerful allies to help keep your patient's healing on track during COVID-19. That’s why we offer a comprehensive portfolio of advanced wound care solutions.
From a Collagen/ORC matrix dressing that can help improve healing rates to antimicrobial dressings17 that can provide an effective barrier to bacterial contamination, and a silicone foam dressing that can help you effectively manage exuding wounds. 3M gives you the solutions and support your wound care patients need to encourage healing and help them get back to their lives.
Venous leg ulcers (VLUs) are the most common type of lower extremity wound, afflicting approximately 1% of the western population during their lifetime.19 With the onset of COVID-19, outpatient clinic visits dropped dramatically and some VLU patients were no longer receiving their weekly assessments and treatment. Delays and interruptions in care can cause wound healing to stall and deteriorate. You can help patients stay on track by focusing on best practices for skin and wound management and incorporating compression therapy as the gold standard of VLU care.
Today, more than ever, your patients deserve innovative 3M skin protectants, wound care dressings and compression systems to help bring the focus back to wound healing and get them back on their feet.
V.A.C.® Therapy has been shown to be a successful way to manage wounds for the past 25 years. Extensive and early use of negative pressure wound therapy (NPWT) can be beneficial in helping prevent wound healing complications and helping to support healing.1
V.A.C.® Therapy has been associated with:
But wait, did you know that V.A.C. VERAFLO™ Therapy has been shown to provide better clinical outcomes overall than V.A.C.® Therapy alone when added to standard of care?20
V.A.C. VERAFLO™ Therapy, when used in conjunction with good clinical practice (e.g., debridement, appropriate antibiotics), has been shown to be more beneficial than V.A.C.® Therapy with respect to:
Studies have shown that faster healing rates may result from earlier use of Advanced Wound Dressing products, which may reduce rates of infection, inflammation and wound chronicity.1,2 Don’t wait. Implement 3M Solutions to help manage bacterial bioburden and bring wound healing back on track and be certain you are helping your patients.
SILVERCEL™ NON-ADHERENT Hydro-Alginate Antimicrobial Dressing with Silver with EASYLIFT™ Precision Film Technology is a nonwoven pad composed of alginate, carboxymethylcellulose (CMC) and silver coated nylon fibers, with EASYLIFT™ Precision Film Technology to help manage, under medical supervision, infected, exuding wounds.
PROMOGRAN™ Protease Modulating Matrix dressing is comprised of a sterile, freeze-dried composite of Oxidized Regenerated Cellulose (ORC), Collagen, with the addition of Silver/ORC in the PROMOGRAN PRISMA™ Wound Balancing Matrix dressing.
Early treatment with V.A.C. VERAFLO™ Therapy can help interrupt the bioburden lifecycle by cleansing the wound and removing solubilized debris and infectious materials!21,22,23
Whilst early initiation of V.A.C.® Therapy on acute and chronic wounds has been shown to reduce length of stay days in acute care, long term acute care, and home health.12-16* 3M offers a range of specialized NPWT solutions to support your individual facility and patient needs.
The V.A.C. ULTA™ Therapy Unit is an integrated wound management system for hospitals that provides Negative Pressure Wound Therapy (V.A.C.® Therapy) with an instillation option (V.A.C. VERAFLO™ Therapy).
The ACTIV.A.C.™ Therapy System was specifically developed for the mobile wound care patient, to help them resume their activities of daily living while still receiving the proven benefits of portable V.A.C.® Therapy.
The SNAP™ Therapy System is a unique and convenient disposable negative pressure wound therapy (dNPWT) solution, ideal for patients that might benefit from silent, hidden, and wearable NPWT.
Protect skin: protect periwound skin areas exposed to moisture, friction and shear
Manage bacterial bioburden that can be present in chronic wounds, including VLUs
Optimize wound environment and manage exudate
Provide therapeutic compression therapy. Compression therapy is the gold standard of care for management of VLUs and has been shown to increase the rate of healing as compared to healing rates without the use of compression.
As your facility prepares for a new business as usual, 3M is dedicated to providing you with the information needed to help keep people protected at every touchpoint.
Find all medical respiratory protection resources in one place, including information about protection options, PPE and skin protection, optimizing your supply and extended use and limited re-use guidance.
*Early NPWT was defined for acute wounds as treatment initiated within the first 7 days from the first wound treatment date and within 30 days for chronic wounds; late NPWT initiation occurred after this time. A secondary analysis was conducted on a sub-set of patients where Charlson Co-morbidity Index Scores ≤5, to assess Early vs. Late cost differences by wound type, excluding the sickest patients with significant non-wound long-term care costs; this cohort represented 80% of the wounds.
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.
© 2020 3M. All rights reserved. 3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited. PRA-PM-EU-00415 (10/20)